Title : Enhanced expression of WD repeat-containing protein 35 via nuclear factor-kappa B activation in bupivacaine-treated Neuro2a cells.

Pub. Date : 2014

PMID : 24466034






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 APDC, an NF-kappaB inhibitor, attenuated the increase in NF-kappaB activity and WDR35 protein expression in bupivacaine-treated Neuro2a cells. Ammonium pyrrolidyldithiocarbamate WD repeat domain 35 Mus musculus